After years of planning, the most impactful changes for the US Food and Drug Administration through the renewal of the prescription drug user fee program may originate in lessons from something that caught many by surprise – the coronavirus pandemic.
Stakeholders will meet on 23 July to formally begin the sixth PDUFA reauthorization process, which will set the course of...